Press Releases

Creative BioMart Enhanced Its Bacterial Expression Service for Research Use

Peptidoglycan Structure Analysis Now Available at CD BioGlyco

Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents

Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Indica Labs and Lunit has announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products.

Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion

Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.

MDClone Synthetic Data Platform Drives Deeper Provider/Life Sciences Collaboration for Therapeutic R&D

Unique platform enables providers to securely connect life science organizations to rich patient data to test hypotheses, develop clinical trials, and create life saving therapies

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency

CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis

CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.

STEMart Launches Bioburden and Sterility Testing for Medical Devices

STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.

PEGylation technology

PEGylation is a revolutionary modification of a therapeutic protein, nucleic acid, or small drug molecule by covalently attaching polyethylene glycol (PEG) or a derivative thereof.

BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.

CD ComputaBio Boosts Small Molecule Drug Development with Protein-Small Molecule Docking Service

High-Performance OLED and PLED Materials

Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.

Advanced Library Amplification Mix Delivers Superior NGS Data Quality

PCR Biosystems has launched the VeriFi™ Library Amplification Mix, combining the powerful and robust proofreading performance of VeriFi™ Hot Start Polymerase with a greatly reduced GC-dependent bias.